Magnendo Autonomous Stroke Robot Secures $32M ARPA-H Funding for Robotic Treatment System

Magnendo, an MIT spinout developing magnetic robotic navigation technology for endovascular procedures, has been awarded up to $32 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop an autonomous system for treating ischemic strokes.

The five-year program will focus on robotic technology designed to navigate blood vessels with less direct input from physicians. The goal is to address challenges associated with mechanical thrombectomy, a standard treatment for severe ischemic strokes caused by large vessel occlusions.

Although thrombectomy can restore blood flow by removing a clot from a blocked artery, the procedure requires highly specialized expertise and is currently available at a limited number of hospitals. Magnendo's magnetic navigation technology aims to improve access to advanced endovascular procedures.

Patients with large vessel occlusions often have complex vascular anatomy that can make catheter navigation technically challenging. Magnendo's system uses magnetic robotic navigation to guide endovascular instruments through the body's vascular system.

The company states that preclinical testing has demonstrated improvements in navigation speed and procedural consistency among physicians with different levels of experience.

The ARPA-H funding will support development of a next-generation platform under the Autonomous Interventions and Robotics (AIR) initiative, led by program manager Ileana Hancu. The program aims to develop robotic systems capable of performing endovascular stroke procedures with progressively less direct human control.

The project will combine magnetic robotics with medical imaging, AI, and other supporting technologies required for autonomous intervention. Magnendo believes autonomous endovascular treatment will require a fundamentally different approach to navigating complex vascular anatomy.

Yoonho Kim, Magnendo's Founder, CEO and Principal Investigator of the AIR program, stated:

"It requires a fundamentally different approach to navigating complex vascular anatomy, and we believe our magnetic robotic navigation is a critical enabling technology for autonomous endovascular intervention."

The ARPA-H award will help Magnendo and its collaborators establish technical and clinical foundations needed to advance autonomous stroke intervention technology toward future clinical applications.